期刊文献+

补气阴法联合小剂量阿糖胞苷治疗初治老年急性单核细胞白血病的临床观察 被引量:1

下载PDF
导出
摘要 目的:观察补气阴法联合小剂量阿糖胞苷治疗初治老年急性单核细胞白血病(AML-M5)的临床疗效。方法:对12例初治老年AML-M5采用小剂量Ara-c50mg/d×10d化疗,联合中成药参麦针及补气阴中药治疗,观察治疗前后临床症状、血常规及骨髓细胞学变化。结果:1个疗程完全缓解率41.7%,总有效率83.3%。2年无复发存活5例,2例死亡;血液毒性反应及消化道反应少,改善较快。结论:补气阴法联合小剂量阿糖胞苷治疗初发老年急性单核细胞白血病的疗效肯定,不良反应少。
出处 《实用中西医结合临床》 2009年第2期17-18,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献1

二级参考文献16

  • 1龙怡,杜欣,翁建宇,林伟.老年急性白血病45例临床分析[J].临床血液学杂志,2004,17(6):313-315. 被引量:12
  • 2全国白血病化学治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183.
  • 3LOWENBERG B. Managing therapy in older adult patients with acute myeloid leukemia[J]. Seminars in Hematology, 2001, 38:10- 16.
  • 4GRIMWADE D, WALKER H, HARRISON G, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML) : analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial[J]. Blood, 2001, 98.1312-1320.
  • 5LEITH C P, KOPECKY K J, GODWIN J, et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study[J]. Blood, 1997, 89:3323-3329.
  • 6GAJEWSKI J L, HOW G, NIMER S D, et al. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome[J].J Clin oncol, 1989, 7:1637-1645.
  • 7PINTO A, ZAGONEL V, FERRARA F. Acute myeloid leukemia in the elderly: biology and therapeutic strategies[J]. Crit Rev Oncol Hematol, 2001, 39.275-287.
  • 8SEKERES M A, STONE R M. The challenge of acute myeloid leukemia in older patients[J]. Curr Opin Oncol, 2002, 14:24-30.
  • 9SCHRICH M, ILLMER T, AULITZKY W, et al.Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years[J]. Haematologica, 2002, 87: 808-815.
  • 10ANDERSON J E, KOPECHY K J, WILLMAN C L,et al. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytara-bine and daunoruhicin: a Southwest Oncology Group study[J]. Blood, 2002, 100.3869-3876.

共引文献3

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部